Crossmark

Targeting ZNF410 as a potential β-hemoglobinopathy therapy

Crossref DOI link: https://doi.org/10.1038/s41588-021-00817-y

Published Online: 2021-04-15

Published Print: 2021-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tumburu, Laxminath https://orcid.org/0000-0002-7548-0243
Thein, Swee Lay https://orcid.org/0000-0002-9835-6501
Funding

Funding for this research was provided by:

Intra-mural NIH
License Information

Text and Data Mining valid from 2021-04-15

Version of Record valid from 2021-04-15
More Information

Article History

First Online: 15 April 2021

Competing interests

: The authors declare no competing interests.